MOLECULAR PATHOLOGY

Diagnosis of Chlamydia trachomatis infection via detection of C. trachomatis DNA.

Evaluation of progressive multifocal leukoencephalopathy and BK virus-associated nephropathy.

It helps determine the specific HCV genotype (1–8), crucial for guiding antiviral therapy selection and treatment duration.

Detects numerical & structural chromosomal abnormalities in the fetus within the assay's limit of detection.

The Hepatitis B Serology Panel assesses hepatitis B virus (HBV) infection status and immunity. This panel helps clinicians diagnose acute or chronic HBV infections, determine if a patient has recovered from past infection, evaluate vaccination status, and guide treatment decisions. It's crucial for screening high-risk individuals, monitoring pregnant women to prevent vertical transmission, and assessing potential blood or organ donors for HBV status.

Detection of EGFR gene mutations most commonly in non-small lung cancer (NSCLC). Identify patients who may benefit from EGFR inhibitors.

Typically ordered for evaluation of recurrent pregnancy losses/ bad obstetric history. Detects numerical & structural chromosomal abnormalities within the assay's limit of detection. This cytogenetic analysis is essential for understanding genetic contributions to diseases and providing targeted medical care​, A normal result does not completely exclude genetic disorders e.g. single gene disorders, submicroscopic cytogenetic abnormalities below the assay's detection limit. Where there is a high residual index of suspicion following a normal result, other tests can be considered e.g. chromosomal microarray (depends on the clinical context).

Assessment of HER2 gene amplification in breast cancer cells in patients with equivocal HER2 IHC results. Determine eligibility for HER2-targeted therapies.